[1] 陶谦,杨耀成.2017年WHO成釉细胞瘤新分类的逻辑性与临床指导意义[J].口腔疾病防治,2020,28(7):416-420. [2] Khojasteh A, Khodayari A, Rahimi F, et al. Hypermethylation of p16 tumor-suppressor gene in ameloblastic carcinoma, ameloblastoma, and dental follicles[J]. J Oral Maxillofac Surg, 2013, 71(1):62-65. [3] Kallianpur S, Jadwani S, Misra B, et al. Ameloblastic carcinoma of the mandible: Report of a case and review[J]. J Oral Maxillofac Pathol, 2014, 18(Suppl 1):S96-S102. [4] Garcia-Munoz A, Bologna-Molina R, Aldape-Barrios B, et al. Identification of proteins with increased levels in ameloblastic carcinoma[J]. J Oral Maxillofac Surg, 2014, 72(6):1183-1196. [5] Li J, DU H, Li P, et al. Ameloblastic carcinoma: An analysis of 12 cases with a review of the literature[J]. Oncol Lett, 2014, 8(2):914-920. [6] Gunaratne DA, Coleman H G, Lim L, et al. Ameloblastic carcinoma[J]. Am J Case Rep, 2015, 16:415-419. [7] Karakida K, Aoki T, Sakamoto H, et al. Ameloblastic carcinoma, secondary type: a case report[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2010, 110(6):e33-e37. [8] Saluja TS, Hosalkar R. Reconnoitre ameloblastic carcinoma: A prognostic update[J]. Oral Oncol, 2018, 77:118-124. [9] McClary AC, West RB, McClary AC, et al. Ameloblastoma: a clinical review and trends in management[J]. Eur Arch Otorhinolaryngol, 2016, 273(7):1649-1661. [10] Yoon HJ, Hong SP, Lee JI, et al. Ameloblastic carcinoma: an analysis of 6 cases with review of the literature[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009, 108(6):904-913. [11] Benlyazid A, Lacroix-Triki M, Aziza R, et al. Ameloblastic carcinoma of the maxilla: case report and review of the literature[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 104(6):e17-e24. [12] Dhir K, Sciubba J, Tufano RP. Ameloblastic carcinoma of the maxilla[J]. Oral Oncol, 2003, 39(7):736-741. [13] Akrish S, Buchner A, Shoshani Y, et al. Ameloblastic carcinoma: report of a new case, literature review, and comparison to ameloblastoma[J]. J Oral Maxillofac Surg, 2007, 65(4):777-783. [14] Kishore M, Panat SR, Aggarwal A, et al. Ameloblastic carcinoma: A case report[J]. J Clin Diagn Res, 2015, 9(7):D27-D28. [15] Makiguchi T, Yokoo S, Miyazaki H, et al. Treatment strategy of a huge ameloblastic carcinoma[J]. J Craniofac Surg, 2013, 24(1):287-290. [16] Mahmoud S, Amer HW, Mohamed SI. Primary ameloblastic carcinoma: literature review with case series[J]. Pol J Pathol, 2018, 69(3):243-253. [17] Bello IO, Alanen K, Slootweg PJ, et al. Alpha-smooth muscle actin within epithelial islands is predictive of ameloblastic carcinoma[J]. Oral Oncol, 2009, 45(9):760-765. [18] Maya R, Sekar B, Murali S. Comparative evaluation of expression of proliferating cell nuclear antigen in variants of ameloblastoma and ameloblastic carcinoma[J]. Indian J Dent Res, 2012, 23(1):15-19. [19] Lei Y, Jaradat JM, Owosho A, et al. Evaluation of SOX2 as a potential marker for ameloblastic carcinoma[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2014, 117(5):608-616. [20] Kar IB, Subramanyam RV, Mishra N, et al. Ameloblastic carcinoma: A clinicopathologic dilemma-Report of two cases with total review of literature from 1984 to 2012[J]. Ann Maxillofac Surg, 2014, 4(1):70-77. [21] Chaisuparat R, Sawangarun W, Scheper MA. A clinicopathological study of malignant odontogenic tumours[J]. Histopathology, 2012, 61(1):107-112. [22] 邹海啸,吴丽芬,李辰,等.颌骨成釉细胞癌10例临床分析[J].口腔医学研究,2018,34(12):1289-1292. [23] Franca DC, Moreira JJ, DE Aguiar SM, et al. Ameloblastic carcinoma of the maxilla: A case report[J]. Oncol Lett, 2012, 4(6):1297-1300. [24] Li D, Xu S, Sun M, et al. MAID chemotherapy regimen as a treatment strategy for metastatic malignant ameloblastoma: A case report[J]. Medicine (Baltimore), 2019, 98(25):e15873. [25] Salami A, Ezenkwa U, Salami M, et al. Malignant ameloblastoma: a challenging diagnosis[J]. Autops Case Rep, 2018, 8(4):e2018043. [26] Datta R, Winston JS, Diaz-Reyes G, et al. Ameloblastic carcinoma: report of an aggressive case with multiple bony metastases[J]. Am J Otolaryngol, 2003, 24(1):64-69. |